A novel cell-based bone graft, one that is going through the rigorous FDA Biologic License Application (BLA) process, has reached an important milestone in its first in-human clinical trials.
PORTLAND, FL, UNITED STATES, November 6, 2024 /EINPresswire / -- A recent study by Allied Market Research on the global bone grafts and substitutes market shows that the industry is anticipated to ...